Benefytt Technologies Inc. and its investors can put behind them a suit alleging the company made misleading statements about deceptive sales practices after a federal judge in Florida granted final approval to their $11 million settlement.
Investors accused Benefytt, formerly known as Health Insurance Innovations Inc., of misleading them about deceptive sales of health plans that didn’t comply with the Affordable Care Act. The settlement class includes those who purchased the health insurance technology company’s common stock from Sept. 25, 2017, through April 11, 2019, the U.S. District Court for the Middle District of Florida said.
Judge William F. ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.